Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?

被引：3
|
作者：
Nguyen, Minh-Vu H. [1 ]
Daley, Charles L. [1 ]
机构：
[1] Natl Jewish Hlth, Div Mycobacterial & Resp Infect, Denver, CO 80206 USA
来源：
CLINICS IN CHEST MEDICINE | 2023年 / 44卷 / 04期
关键词：
Mycobacterium avium complex; Nontuberculous mycobacteria; Azithromycin; Amikacin; Macrolide-resistance; COMPLEX LUNG-DISEASE; AVIUM COMPLEX; SP-NOV; CLINICAL-SIGNIFICANCE; MACROLIDE RESISTANCE; TREATMENT OUTCOMES; NITRIC-OXIDE; DOUBLE-BLIND; CLARITHROMYCIN; AZITHROMYCIN;
D O I：
10.1016/j.ccm.2023.06.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：771 / 783
页数：13
相关论文
共 50 条
  • [21] What athletes often ask - Should I train when I have a cold and if not when can I return?
    Young, M
    BRITISH JOURNAL OF SPORTS MEDICINE, 1998, 32 (01) : 84 - 84
  • [22] When should I start using a new biomarker: Focus on expression arrays?
    Desmedt, C.
    Sotiriou, C.
    EJC SUPPLEMENTS, 2007, 5 (05): : 97 - 104
  • [23] Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
    Kim, Bo-Guen
    Jhun, Byung Woo
    Kim, Hojoong
    Kwon, O. Jung
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
    Bo-Guen Kim
    Byung Woo Jhun
    Hojoong Kim
    O Jung Kwon
    Scientific Reports, 12
  • [25] Phosphate binders in chronic kidney disease. When should we start, what should we prescribe?
    Malindretos, Pavlos
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (16) : 2255 - 2256
  • [26] Mycobacterium avium complex pulmonary disease patients with limited treatment options
    Aliberti, Stefano
    Blasi, Francesco
    Burgel, Pierre-Regis
    Calcagno, Andrea
    Floe, Andreas
    Grogono, Dorothy
    Papavasileiou, Apostolos
    Polverino, Eva
    Prados, Concepcion
    Rohde, Gernot
    Salzer, Helmut J. F.
    Sanchez-Montalva, Adrian
    Shteinberg, Michal
    Van Braeckel, Eva
    van Ingen, Jakko
    Veziris, Nicolas
    Wagner, Dirk
    Loebinger, Michael R.
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [27] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Hyung-Jun Kim
    Jong Sik Lee
    Nakwon Kwak
    Jaeyoung Cho
    Chang-Hoon Lee
    Sung Koo Han
    Jae-Joon Yim
    BMC Pulmonary Medicine, 19
  • [28] Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease
    Deshpande, Devyani
    Srivastava, Shashikant
    Pasipanodya, Jotam G.
    Lee, Pooi S.
    Gumbo, Tawanda
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 : 30 - 35
  • [29] Oral β-Lactam Pairs for the Treatment of Mycobacterium avium Complex Pulmonary Disease
    Negatu, Dereje A.
    Shin, Sung Jae
    Kim, Su-Young
    Jhun, Byung Woo
    Dartois, Veronique
    Dick, Thomas
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (02): : e241 - e246
  • [30] Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
    Kim, Hyung-Jun
    Lee, Jong Sik
    Kwak, Nakwon
    Cho, Jaeyoung
    Lee, Chang-Hoon
    Han, Sung Koo
    Yim, Jae-Joon
    BMC PULMONARY MEDICINE, 2019, 19 (01)
12345